News
Abbott (NYSE:ABT) today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM ...
Emma Gill had bee been warned about her blood sugar levels being too high before, so she tested out a continuous glucose ...
It was a couple of years ago now I was warned about my blood sugar being too high. Eventually, after two successive high ...
Richard Bernstein was flipping through a medical trade journal in 1969 when he saw an advertisement for a device that could ...
People living with type 1 diabetes who choose to use twiist will have the flexibility to select from two compatible CGM partners, the Senseonics Eversense 365 and Abbott's FreeStyle Libre 3 Plus ...
Injectable medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1 medications) — are helping people manage blood sugar, support weight loss, and improve overall well-being.
You get it from the carbohydrates you consume. Glucose is the primary energy source for your body's cells, tissues, and organs. Monitoring your blood sugar can help prevent serious complications ...
Glucose values in patients with type 1 diabetes (T1D) may vary based on the continuous glucose monitoring (CGM ... upper arms from three CGM systems: FreeStyle Libre 3 (FL3; Abbott Diabetes ...
Based on FreeStyle Libre, we designed QT AIR, an advanced real-time, calibrated Continuous Glucose Monitoring (CGM) device. This study aim to validate the consistency and clinical accuracy of the ...
Their approach, based on continuous glucose monitoring (CGM) data, could improve early detection and risk assessment for diabetes without relying on blood samples and expensive or complex procedures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results